Cargando…

Could SARS-CoV-2 herald a surge of multiple sclerosis?

During the current COVID-19 pandemic, many queries are raised regarding its nature, outcome, and sequelae. This letter raises the concern of potential impact on increasing the incidence of multiple sclerosis whose pathology involves a possible viral etiology. Besides, the potential neurotropism of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalaby, Nevin Mohieldin, Shehata, Hatem Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874024/
https://www.ncbi.nlm.nih.gov/pubmed/33584093
http://dx.doi.org/10.1186/s41983-021-00277-5
_version_ 1783649501644324864
author Shalaby, Nevin Mohieldin
Shehata, Hatem Samir
author_facet Shalaby, Nevin Mohieldin
Shehata, Hatem Samir
author_sort Shalaby, Nevin Mohieldin
collection PubMed
description During the current COVID-19 pandemic, many queries are raised regarding its nature, outcome, and sequelae. This letter raises the concern of potential impact on increasing the incidence of multiple sclerosis whose pathology involves a possible viral etiology. Besides, the potential neurotropism of the acute respiratory distress syndrome corona virus-2 (SARS-CoV-2), which is still not established, may raise concerns about the use of certain disease modifying therapies namely natalizumab.
format Online
Article
Text
id pubmed-7874024
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78740242021-02-10 Could SARS-CoV-2 herald a surge of multiple sclerosis? Shalaby, Nevin Mohieldin Shehata, Hatem Samir Egypt J Neurol Psychiatr Neurosurg Letter to the Editor During the current COVID-19 pandemic, many queries are raised regarding its nature, outcome, and sequelae. This letter raises the concern of potential impact on increasing the incidence of multiple sclerosis whose pathology involves a possible viral etiology. Besides, the potential neurotropism of the acute respiratory distress syndrome corona virus-2 (SARS-CoV-2), which is still not established, may raise concerns about the use of certain disease modifying therapies namely natalizumab. Springer Berlin Heidelberg 2021-02-10 2021 /pmc/articles/PMC7874024/ /pubmed/33584093 http://dx.doi.org/10.1186/s41983-021-00277-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Shalaby, Nevin Mohieldin
Shehata, Hatem Samir
Could SARS-CoV-2 herald a surge of multiple sclerosis?
title Could SARS-CoV-2 herald a surge of multiple sclerosis?
title_full Could SARS-CoV-2 herald a surge of multiple sclerosis?
title_fullStr Could SARS-CoV-2 herald a surge of multiple sclerosis?
title_full_unstemmed Could SARS-CoV-2 herald a surge of multiple sclerosis?
title_short Could SARS-CoV-2 herald a surge of multiple sclerosis?
title_sort could sars-cov-2 herald a surge of multiple sclerosis?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874024/
https://www.ncbi.nlm.nih.gov/pubmed/33584093
http://dx.doi.org/10.1186/s41983-021-00277-5
work_keys_str_mv AT shalabynevinmohieldin couldsarscov2heraldasurgeofmultiplesclerosis
AT shehatahatemsamir couldsarscov2heraldasurgeofmultiplesclerosis